FDA inspection

Glaukos Corporation: FDA inspection ending Jul 19, 2023

FDA inspection 1211136 · No Action Indicated (NAI) · San Clemente, CA

Key facts

Inspection ID 1211136
Firm Glaukos Corporation
FEI number 3012341472
Address 229 Avenida Fabricante
City San Clemente
State CA
ZIP 92672-7531
Fiscal year 2023
Inspection end date Jul 19, 2023
Classification No Action Indicated (NAI)
Project area New Drug Evaluation
Product type Drugs

At a glance

  • None Citations
  • None Posted citations
  • No Warning letter followed
  • Yes Form FDA 483 issued
  • Yes Establishment inspection report (EIR) exists
  • 1–9 Inspections at this FEI

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About FDA inspections

FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.

Source: U.S. Food and Drug Administration (FDA), inspection classification data

Browse all FDA inspections